Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2019 Q2- Text added to 2019 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
alpha, antimicrobial, Astra, automimmune, biomarin, Canada, career, Celgene, deep, default, deliverable, dermatologist, Dr, drawn, drew, Dummer, elosulfase, expansion, flexibility, floor, formal, Genentech, immunotherapy, Israel, led, LIBOR, loan, Medison, MidCap, opinion, payable, peer, perfected, PK, premium, prepayment, ratably, refinance, repay, Roche, tranche, trend, Trust, unamortized, unpaid, vice, Vimizim, Wolfgang, Zeneca
Removed:
FIFO, half, IL, submitted
Valuein 2019 Q2 filing- Value in 2019 Q3 filing
Original filings
Filing view